Moleculin Biotech MBRX Stock
Moleculin Biotech Price Chart
Moleculin Biotech MBRX Financial and Trading Overview
| Moleculin Biotech stock price | 0.81 USD |
| Previous Close | 0.59 USD |
| Open | 0.55 USD |
| Bid | 0 USD x 1400 |
| Ask | 0 USD x 800 |
| Day's Range | 0.55 - 0.61 USD |
| 52 Week Range | 0.55 - 1.94 USD |
| Volume | 821.77K USD |
| Avg. Volume | 271.65K USD |
| Market Cap | 17.51M USD |
| Beta (5Y Monthly) | 1.993661 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -6.32 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 8.67 USD |
MBRX Valuation Measures
| Enterprise Value | -19303040 USD |
| Trailing P/E | N/A |
| Forward P/E | -0.6344086 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.382372 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | 0.607 |
Trading Information
Moleculin Biotech Stock Price History
| Beta (5Y Monthly) | 1.993661 |
| 52-Week Change | -60.40% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 1.94 USD |
| 52 Week Low | 0.55 USD |
| 50-Day Moving Average | 0.72 USD |
| 200-Day Moving Average | 1.06 USD |
MBRX Share Statistics
| Avg. Volume (3 month) | 271.65K USD |
| Avg. Daily Volume (10-Days) | 143.3K USD |
| Shares Outstanding | 29.68M |
| Float | 28.84M |
| Short Ratio | 0.05 |
| % Held by Insiders | 2.82% |
| % Held by Institutions | 10.16% |
| Shares Short | 8.04K |
| Short % of Float | 0.029% |
| Short % of Shares Outstanding | 0.029% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:6 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -30.72% |
| Return on Equity (ttm) | -50.82% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -31792000 USD |
| Net Income Avi to Common (ttm) | -30073000 USD |
| Diluted EPS (ttm) | -1.01 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 37.27M USD |
| Total Cash Per Share (mrq) | 1.26 USD |
| Total Debt (mrq) | 308K USD |
| Total Debt/Equity (mrq) | 0.67 USD |
| Current Ratio (mrq) | 7.808 |
| Book Value Per Share (mrq) | 1.543 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -28851000 USD |
| Levered Free Cash Flow (ttm) | -17831000 USD |
Profile of Moleculin Biotech
| Country | United States |
| State | TX |
| City | Houston |
| Address | 5300 Memorial Drive |
| ZIP | 77007 |
| Phone | 713 300 5160 |
| Website | https://www.moleculin.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 15 |
Moleculin Biotech, Inc., a clinical stage pharmaceutical company, focuses on the development of drug candidates for the treatment of cancers and viruses. Its lead drug candidate is Annamycin, which is in Phase 1/2 studies for the treatment of relapsed or refractory acute myeloid leukemia (AML) and cancers metastasized to the lungs. The company's flagship immune/transcription modulator is WP1066 that is in Phase I clinical trial for the treatment of brain tumors and pediatric brain tumors, as well as pancreatic cancer and other malignancies. It is also developing WP1220, an analog of WP1066 for the topical treatment of cutaneous T-cell lymphoma; and WP1122 to treat glioblastoma multiforme and COVID-19. The company was incorporated in 2015 and is headquartered in Houston, Texas.
Q&A For Moleculin Biotech Stock
What is a current MBRX stock price?
Moleculin Biotech MBRX stock price today per share is 0.81 USD.
How to purchase Moleculin Biotech stock?
You can buy MBRX shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Moleculin Biotech?
The stock symbol or ticker of Moleculin Biotech is MBRX.
Which industry does the Moleculin Biotech company belong to?
The Moleculin Biotech industry is Biotechnology.
How many shares does Moleculin Biotech have in circulation?
The max supply of Moleculin Biotech shares is 13.3M.
What is Moleculin Biotech Price to Earnings Ratio (PE Ratio)?
Moleculin Biotech PE Ratio is now.
What was Moleculin Biotech earnings per share over the trailing 12 months (TTM)?
Moleculin Biotech EPS is -6.32 USD over the trailing 12 months.
Which sector does the Moleculin Biotech company belong to?
The Moleculin Biotech sector is Healthcare.
Moleculin Biotech MBRX included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 15517.08 USD — |
-0.45
|
2.74B USD — | 14784.03 USD — | 16292.28 USD — | — - | 2.74B USD — |
| NASDAQ Capital Market Composite RCMP | 92.76 USD — |
+0.65
|
— — | 86.91 USD — | 95.14 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 865.71 USD — |
-0.47
|
— — | 828.4 USD — | 890 USD — | — - | — — |
- {{ link.label }} {{link}}